Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects women of all ages and causes a wide range of symptoms.[1] The current name "polycystic ovary syndrome" is misleading because it implies the presence of true cysts on the ovaries, although they are immature eggs or follicles that have stopped growing.[1][2][4] This name overlooks systemic hormonal and metabolic disorders, leading to confusion, delayed diagnosis, and inadequate care.[1][2] Experts are proposing new names such as "hyperandrogenic anovulation", "metabolic-reproductive syndrome" or "ovarian dysmetabolic syndrome" to better reflect the overall scope of the disease.[1][2] A 2023 global survey of 7,708 participants showed that 76% of health professionals and 86% of patients supported the name change.[2] The name change should increase understanding among physicians, reduce stigma, and improve disease management.[1][2] PCOS is the most common endocrine disorder in women of reproductive age, affecting 5 to 10% of women aged 18 to 44.[2][3]